PALUMBO, CARLOTTA
 Distribuzione geografica
Continente #
EU - Europa 2.730
AS - Asia 2.415
NA - Nord America 1.901
SA - Sud America 204
AF - Africa 66
OC - Oceania 3
AN - Antartide 1
Totale 7.320
Nazione #
US - Stati Uniti d'America 1.811
SG - Singapore 1.161
RU - Federazione Russa 1.040
IE - Irlanda 757
HK - Hong Kong 391
CN - Cina 359
SE - Svezia 268
VN - Vietnam 215
DE - Germania 197
FR - Francia 143
BR - Brasile 141
IT - Italia 92
GB - Regno Unito 75
BD - Bangladesh 59
IN - India 57
CA - Canada 54
KR - Corea 41
FI - Finlandia 36
MX - Messico 27
BJ - Benin 26
PL - Polonia 25
AR - Argentina 24
UA - Ucraina 22
JP - Giappone 20
IQ - Iraq 18
ID - Indonesia 16
ZA - Sudafrica 16
NL - Olanda 15
TR - Turchia 15
PE - Perù 13
ES - Italia 12
EC - Ecuador 9
LT - Lituania 7
MA - Marocco 7
MY - Malesia 7
PH - Filippine 7
PK - Pakistan 7
CZ - Repubblica Ceca 6
RO - Romania 6
SA - Arabia Saudita 6
AT - Austria 5
CH - Svizzera 5
IL - Israele 5
TH - Thailandia 5
UZ - Uzbekistan 5
VE - Venezuela 5
BE - Belgio 4
NP - Nepal 4
TN - Tunisia 4
AE - Emirati Arabi Uniti 3
CO - Colombia 3
DZ - Algeria 3
LV - Lettonia 3
PY - Paraguay 3
RS - Serbia 3
AU - Australia 2
AZ - Azerbaigian 2
CL - Cile 2
CR - Costa Rica 2
HN - Honduras 2
JM - Giamaica 2
KZ - Kazakistan 2
OM - Oman 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
TW - Taiwan 2
AO - Angola 1
AQ - Antartide 1
BF - Burkina Faso 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EG - Egitto 1
ET - Etiopia 1
GD - Grenada 1
GR - Grecia 1
GY - Guiana 1
HR - Croazia 1
JO - Giordania 1
KE - Kenya 1
LB - Libano 1
MD - Moldavia 1
MR - Mauritania 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PA - Panama 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
SI - Slovenia 1
SR - Suriname 1
ST - Sao Tome e Principe 1
UY - Uruguay 1
Totale 7.320
Città #
Dublin 755
Hong Kong 390
Singapore 358
San Jose 299
Council Bluffs 190
Ashburn 181
Beijing 161
Lauterbourg 111
Lawrence 107
Princeton 107
Los Angeles 85
Bremen 78
Moscow 72
Ho Chi Minh City 65
Santa Clara 56
Columbus 55
Hanoi 46
New York 43
Seoul 39
Buffalo 38
Helsinki 34
Boardman 29
Munich 29
Cotonou 26
São Paulo 23
Warsaw 22
Chennai 20
Orem 20
Montreal 18
Toronto 18
Dallas 17
London 17
Mexico City 17
Tokyo 17
Brooklyn 16
Frankfurt am Main 16
Atlanta 14
Chicago 13
Boston 12
Denver 11
Lima 11
Amsterdam 10
Ankara 10
Falkenstein 10
Genoa 10
Mumbai 10
Novara 10
Rome 10
Guangzhou 9
Houston 9
Johannesburg 9
Manchester 9
Milan 9
Phoenix 9
Poplar 9
San Francisco 9
Baghdad 8
Paris 8
St Louis 8
Stockholm 8
Dhaka 7
Jacksonville 7
Nuremberg 7
Tianjin 7
Assago 6
Biên Hòa 6
Haiphong 6
Barnet 5
Bucharest 5
Can Tho 5
Guayaquil 5
Hải Dương 5
Portland 5
Seattle 5
Tashkent 5
Alessandria 4
Brno 4
Chandler 4
City of London 4
Da Nang 4
Des Moines 4
Hangzhou 4
Kuala Lumpur 4
Lahore 4
Roubaix 4
Belo Horizonte 3
Berlin 3
Bismarck 3
Brasília 3
Brussels 3
Curitiba 3
Erbil 3
Kyiv 3
Las Vegas 3
Miami 3
New Delhi 3
Ottawa 3
Padua 3
Pittsburgh 3
Pune 3
Totale 3.981
Nome #
Tumor enlargement in adrenal incidentaloma is related to glaucoma: a new prognostic feature? 124
Assessment of predictors of renal cell carcinoma progression after nephrectomy at short and intermediate term follow-up and implication on surveillance protocols 119
The prognostic role of histomorphological subtyping in nonmetastatic papillary renal cell carcinoma after curative surgery: is subtype really irrelevant? A propensity score matching analysis of a multi-institutional real life data 103
Below Safety Limits, Every Unit of Glomerular Filtration Rate Counts: Assessing the Relationship Between Renal Function and Cancer-specific Mortality in Renal Cell Carcinoma 97
Is active surveillance a safe option for small RCCs as it is for small renal masses? 95
Assessment of local tumor ablation and non-interventional management versus partial nephrectomy in T1a renal cell carcinoma 90
Comparison of survival outcomes in patients with metastatic papillary vs. clear-cell renal cell carcinoma: a propensity-score analysis 88
Adherence to Guideline Recommendations for Perioperative Chemotherapy in Patients with pN2-3 M0 Squamous Cell Carcinoma of the Penis: Temporal Trends and Survival Outcomes 88
Risk of recurrence after nephrectomy: Comparison of predictive ability of validated risk models 87
Bone mineral density and frax score may not predict fracture risk in patients with cancer undergoing hormone deprivation therapies 87
Renal cell carcinoma incidence rates and trends in young adults aged 20-39 years 85
Bladder tumours in children: An interesting case report of TCC with a partial inverted growth pattern 84
Assessment of other-cause mortality in localized renal cell carcinoma patients within 15 years: A population-based analysis 83
Overview of potential determinants of radical prostatectomy versus radiation therapy in management of clinically localized prostate cancer: Results from an Italian, prospective, observational study (the Pros-IT CNR study) 83
Bladder cancer incidence rates and trends in young adults aged 20-39 years 80
Adherence to guideline recommendations for lymph node dissection in squamous cell carcinoma of the penis: Effect on survival and complication rates 80
Complication rates, failure to rescue and in-hospital mortality after cytoreductive nephrectomy in the older patients 78
Changes in body composition and lipid profile in prostate cancer patients without bone metastases given Degarelix treatment: the BLADE prospective cohort study 78
A 25-year Period Analysis of Other-cause Mortality in Localized Prostate Cancer 77
Association Between Systemic Therapy and/or Cytoreductive Nephrectomy and Survival in Contemporary Metastatic Non–clear Cell Renal Cell Carcinoma Patients 77
The effect of age on cancer-specific mortality in patients with prostate cancer: a population-based study across all stages 75
Association of preoperative serum De Ritis ratio with oncological outcomes in patients treated with cytoreductive nephrectomy for metastatic renal cell carcinoma 74
A Plea for Optimizing Selection in Current Adjuvant Immunotherapy Trials for High-risk Nonmetastatic Renal Cell Carcinoma According to Expected Cancer-specific Mortality 74
Adherence to guideline recommendations for multimodality treatment of patients with pT2–3 M0 non-urothelial carcinoma of the urinary bladder: Temporal trends and survival outcomes 73
Biological effect of neoadjuvant androgen-deprivation therapy assessed on specimens from radical prostatectomy: A systematic review 72
Impact of Surgical Approach on Patient-Reported Outcomes after Radical Prostatectomy: A Propensity Score-Weighted Analysis from a Multicenter, Prospective, Observational Study (The Pros-IT CNR Study) 70
Trifecta Outcomes of Partial Nephrectomy in Patients Over 75 Years Old: Analysis of the REnal SURGery in Elderly (RESURGE) Group 67
Primary large cell neuroendocrine carcinoma of the renal pelvis: a case report 65
Relationship between circulating FSH levels and body composition and bone health in patients with prostate cancer who undergo androgen deprivation therapy: The BLADE study 64
Prognostic value of preoperative albumin to globulin ratio in patients treated with salvage radical prostatectomy for radiation recurrent prostate cancer 64
Contemporary North-American population-based validation of the International Germ Cell Consensus Classification for metastatic germ cell tumors of the testis 64
Long-term incidence of secondary bladder and rectal cancer in patients treated with brachytherapy for localized prostate cancer: a large-scale population-based analysis 63
Analysis of circulating tumor cells in prostate cancer patients at psa recurrence and review of the literature 63
Contemporary Age-adjusted Incidence and Mortality Rates of Renal Cell Carcinoma: Analysis According to Gender, Race, Stage, Grade, and Histology 63
Effect of Degarelix administration on bone health in prostate cancer patients without bone metastases. The Blade study. 62
Sex- and age-related differences in the distribution of bladder cancer metastases 62
Partial versus radical nephrectomy in very elderly patients: a propensity score analysis of surgical, functional and oncologic outcomes (RESURGE project) 61
Rates and Predictors of Perioperative Complications in Cytoreductive Nephrectomy: Analysis of the Registry for Metastatic Renal Cell Carcinoma 61
Contemporary Assessment of Long-Term Survival Rates in Patients With Stage I Nonseminoma Germ-Cell Tumor of the Testis: Population-Based Comparison Between Surveillance and Active Treatment After Initial Orchiectomy 61
Differences in short-term outcomes between open versus robot-assisted radical cystectomy in frail malnourished patients 60
Robot-assisted Partial Nephrectomy and Bilateral Pyelolithotomy in Ectopic Pelvic Kidneys 60
Robotic prostatectomy: An update on functional and oncologic outcomes 60
Single-port robotic partial nephrectomy: impact on perioperative outcomes and hospital stay 59
Preoperative proteinuria correlates with renal function after partial nephrectomy for renal cell carcinoma 59
Survival outcomes of radical prostatectomy vs. external beam radiation therapy in prostate cancer patients with Gleason Score 9-10 at biopsy: A population-based analysis 59
Impact of Obesity on Perioperative Outcomes at Robotic-assisted and Open Radical Prostatectomy: Results From the National Inpatient Sample 59
Survival of contemporary patients with non-metastatic urachal vs. non-urachal adenocarcinoma of the urinary bladder 59
Histotype predicts the rate of lymph node invasion at nephrectomy in patients with nonmetastatic renal cell carcinoma 59
Artificial Intelligence in Renal Cell Carcinoma Histopathology: Current Applications and Future Perspectives 58
Prognostic Significance of Grade Discrepancy Between Primary Tumor and Venous Thrombus in Nonmetastatic Clear-cell Renal Cell Carcinoma: Analysis of the REMEMBER Registry and Implications for Adjuvant Therapy 58
Corrigendum to 'Development of a Novel Risk Score to Select the Optimal Candidate for Cytoreductive Nephrectomy Among Patients with Metastatic Renal Cell Carcinoma. Results from a Multi-institutional Registry (REMARCC)' [European Urology Oncology 3 (2021) 256-263 58
Prognostic role of the systemic immune–inflammation index in upper tract urothelial carcinoma treated with radical nephroureterectomy: results from a large multicenter international collaboration 58
Holographic Reconstructions for Preoperative Planning before Partial Nephrectomy: A Head-to-Head Comparison with Standard CT Scan 58
How cancer-specific mortality changes over time after radical cystectomy: Conditional survival of patients with nonmetastatic urothelial carcinoma of the urinary bladder 58
European Association of Urology Guidelines on Renal Cell Carcinoma: The 2025 Update 57
Contemporary Assessment of Survival Rates in Stage I Testicular Seminoma: A Population-Based Comparison Between Surveillance and Active Treatment After Orchiectomy 57
Concordance between biopsy and radical prostatectomy specimen gleason score in internal and external pathology facilities 57
Perineural invasion as a predictor of extraprostatic extension of prostate cancer: A systematic review and meta-analysis 56
Renal Cell Carcinoma: Comparison between Variant Histology and Clear Cell Carcinoma across All Stages and Treatment Modalities 56
Development of a Novel Risk Score to Select the Optimal Candidate for Cytoreductive Nephrectomy Among Patients with Metastatic Renal Cell Carcinoma. Results from a Multi-institutional Registry (REMARCC) 56
Partial nephrectomy for renal tumors: recommendations of the Italian Society of Urology RCC working group 54
Radical cystectomy plus chemotherapy in patients with pure squamous cell bladder carcinoma: a population-based study 54
Prognostic effect of preoperative serum albumin to globulin ratio in patients treated with cytoreductive nephrectomy for metastatic renal cell carcinoma 53
Partial nephrectomy in frail patients: Benefits of robot-assisted surgery 53
Prostate cancer characteristics and cancer-specific mortality of Native American patients 53
The Association Between Cytoreductive Nephrectomy and Overall Survival in Metastatic Renal Cell Carcinoma with Primary Tumor Size ≤4 cm 52
Patient frailty predicts worse perioperative outcomes and higher cost after radical cystectomy worse radical cystectomy outcomes in frails 52
Unmarried men have worse oncologic outcomes after radical cystectomy for nonmetastatic urothelial bladder cancer 52
Massive recurring angiomyxoma of the scrotum in a obese man 52
Long-term Prognostic Impact of Chromosome Abnormalities in Clear Cell Renal Cell Carcinoma 52
Renal Function Impairment Below Safety Limits Correlates With Cancer-specific Mortality in Localized Renal Cell Carcinoma: Results From a Single-center Study 52
Synchronous Metastasis Rates in T1 Renal Cell Carcinoma: A Surveillance, Epidemiology, and End Results Database–based Study 52
Effect of stage and grade migration on cancer specific mortality in renal cell carcinoma patients, according to clear cell vs. non-clear cell histology: A contemporary population-based analysis 52
Proposal for a Two-Tier Re-classification of Stage IV/M1 domain of Renal Cell Carcinoma into M1 ("Oligometastatic") and M2 ("Polymetastatic") subdomains: Analysis of the Registry for Metastatic Renal Cell Carcinoma (REMARCC) 51
Survival of Contemporary Patients With Non-metastatic Small-cell Carcinoma of Urinary Bladder, According to Alternative Treatment Modalities 51
External beam radiation therapy improves survival in high- and intermediate-risk non-metastatic octogenarian prostate cancer patients 51
Outcomes of Partial and Radical Nephrectomy in Octogenarians – A Multicenter International Study (Resurge) 51
Diagnostic Biopsy for Small Renal Tumours: A Survey of Current European Practice 50
Preoperative frailty predicts adverse short-term postoperative outcomes in patients treated with radical prostatectomy 50
Histologic Subtype, Tumor Grade, Tumor Size, and Race Can Accurately Predict the Probability of Synchronous Metastases in T2 Renal Cell Carcinoma 50
Reply to Wei Qi’s letter to the editor about “Preoperative proteinuria correlates with renal function after partial nephrectomy for renal cell carcinoma” 49
The effect of sex on disease stage and survival after radical cystectomy: a population-based analysis 49
Efficacy of the EDP-M scheme plus adjunctive surgery in the management of patients with advanced adrenocortical carcinoma: The brescia experience 49
Rates of other-cause mortality after radical cystectomy are decreasing over time—A population-based analysis over two decades 48
Contemporary Incidence and Mortality Rates in Patients With Testicular Germ Cell Tumors 48
Conditional survival of patients with stage I–III squamous cell carcinoma of the penis: temporal changes in cancer-specific mortality 47
Cryoablation Predisposes to Higher Cancer Specific Mortality Relative to Partial Nephrectomy in Patients with Nonmetastatic pT1b Kidney Cancer 47
Survival and complication rates of metastasectomy in patients with metastatic renal cell carcinoma treated exclusively with targeted therapy: A Combined Population-based Analysis 47
Updated European Association of Urology Guidelines on the Use of Adjuvant Immune Checkpoint Inhibitors and Subsequent Therapy for Renal Cell Carcinoma 46
Conditional survival of patients with nonmetastatic renal cell carcinoma: How cancer-specific mortality changes after nephrectomy 46
Primary lymphomas of the genitourinary tract: A population-based study 46
Prognostic role of delay before radical cystectomy: Retrospective analysis of a single-center cohort with 376 patients 46
Partial vs. radical nephrectomy in pT3a renal cancer: Cancer-specific mortality according to fat invasion pattern 45
Prostate cancer grade and stage misclassification in active surveillance candidates: Black versus white patients 45
The effect of radical cystectomy on survival in patients with metastatic urothelial carcinoma of the urinary bladder 45
Metabolic syndrome predicts worse perioperative outcomes in patients treated with radical prostatectomy for non-metastatic prostate cancer 45
Increasing Rates of Perioperative Chemotherapy are Associated With Improved Survival in Men With Urothelial Bladder Cancer With Prostatic Stromal Invasion 45
Survival After Partial Cystectomy for Variant Histology Bladder Cancer Compared With Urothelial Carcinoma: A Population-based Study 45
Impact of Tumor Size on Cancer-Specific Mortality Rate after Local Tumor Ablation in T1a Renal-Cell Carcinoma 45
Standard vs delayed ligature of the dorsal vascular complex during robot-assisted radical prostatectomy: results from a randomized controlled trial 44
Totale 6.226
Categoria #
all - tutte 44.826
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.826


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022134 1 2 1 2 0 0 0 0 5 0 13 110
2022/20231.206 142 70 53 3 80 67 13 75 687 7 7 2
2023/2024458 17 34 40 15 100 0 145 2 3 6 8 88
2024/20251.444 42 3 67 9 26 43 163 86 442 300 21 242
2025/20264.114 203 231 185 349 352 273 613 671 276 483 200 278
Totale 7.372